Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Blood Irradiation market size was valued at USD 54.64 Million in 2022 and will reach USD 95.87 Million in 2028, with a CAGR of 9.82% during 2022-2028.
Blood irradiation is a therapy in which blood components are irradiated prior to transfusion, to prevent proliferation of certain types of T lymphocytes. These T lymphocytes inhibit the immune responses and can cause a rare graft-versus-host disease (GVHD) with serious complication due to blood transfusion caused by white blood cells. A small number of white blood cells can recognize the different blood in the body which may cause serious illness or death.
COVID-19 objectively improves the infection prevention and control capabilities of blood exposure companies
With the spread of the novel coronavirus pneumonia epidemic around the world, the World Health Organization classifies the novel coronavirus pneumonia epidemic as a global pandemic. This epidemic has brought severe challenges to the public health undertakings of all countries. It has also brought about major economic problems and inevitably caused negative effects. However, COVID-19 has objectively improved the infection prevention and control business of the blood irradiation company and can test the company's efficient operation capabilities. In order to cope with the negative impact of the epidemic, blood exposure companies will adopt a variety of methods to promote the rapid normalization of major business areas, maintain and meet the normal needs of customers during the epidemic, and minimize adverse effects.
Innovative research on laser blood irradiation against COVID-19
Many scientists have confirmed the importance of basic research to study the pathogenic mechanism of COVID-19 destroying various organs and systems in the human body, to prove and develop new treatment methods using laser blood irradiation. It is noted that it is necessary to consider and comprehensively evaluate the results of world scientific research on the development of a vaccine for large-scale prevention of coronavirus infection, and the possibility of global scientists to solve this problem.
Under the public background of the COVID-19 crisis, the industry is being affected by COVID-19. It is currently impossible to accurately predict the degree of control of this epidemic in various countries, and it is impossible to predict whether it will function normally for long-term economic activities.
However, historical data shows that the impact of natural disasters on the macro economy is usually short-term, and the economy often shows a V-shaped trend. Affected by the disaster and market sentiment, the economic growth rate usually drops sharply in a short period of time, but as the disaster is gradually controlled, the market sentiment returns to stability, and the temporarily suppressed consumption and investment needs will be released, resulting in Economic rebound. The outbreak of the epidemic will have a significant impact on enterprises and individuals within a certain period of time, especially on small and medium-sized enterprises and low-income families. It is necessary for the government to take targeted financial and monetary measures to help all walks of life together.
Region Overview:
From 2022-2027, North America is estimated to witness robust growth prospects
Company Overview:
Hitaci, Best Theratronics, Gilardon iwere the top 3 players in the Blood Irradiation market in 2022, taking up a market share of 74% together.
Segmentation Overview:
Among different product types, X-ray Blood Irradiation segment is anticipated to contribute the largest market share in 2027.
X-ray Blood Irradiation
X-ray blood irradiation uses X-ray tubes to generate X-rays instead of isotope sources. When the tube is powered on, radiation is generated, and the radiation output can be stopped when the power is turned off, which ensures the controllable environmental radiation hazard from the working principle. X-rays are widely used in the medical field, with mature protection technology and no radioactive waste. Compared with gamma rays, X-rays are safer and more reliable in terms of personnel operation, management and maintenance.
Gamma-ray Blood Irradiation
The principle of gamma-ray radiation to prevent TA-GCHD is to use the radiation generated in the decay of the radioisotope 137Cs to penetrate nucleated cells, directly cause irreversible damage to nuclear DNA and interfere with its normal repair process, causing lymphocytes to lose mitotic activity and stop proliferation.
Application Overview:
By application, the Blood Bank segment occupied the biggest share from 2017 to 2022.
The Blood Irradiation market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Blood Irradiation market covered in Chapter 4:
Gilardoni
CIF medical
Hitaci
JL SHEPHERD & ASSOCIATES
Gamma-Service
Shinva Medical
Rad Source
Best Theratronics
In Chapter 12 and Chapter 14.1, on the basis of types, the Blood Irradiation market from 2018 to 2028 is primarily split into:
X-ray Blood Irradiation
Gamma-ray Blood Irradiation
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Blood Irradiation market from 2018 to 2028 covers:
Blood Bank
Hospital
Research Institutions
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Blood Irradiation market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Blood Irradiation market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Blood Irradiation industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Blood Irradiation industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Blood Irradiation market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Blood Irradiation market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Blood Irradiation market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Blood Irradiation market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
2022
Blood irradiation is a therapy in which blood components are irradiated prior to transfusion, to prevent proliferation of certain types of T lymphocytes. These T lymphocytes inhibit the immune responses and can cause a rare graft-versus-host disease (GVHD) with serious complication due to blood transfusion caused by white blood cells. A small number of white blood cells can recognize the different blood in the body which may cause serious illness or death.
COVID-19 objectively improves the infection prevention and control capabilities of blood exposure companies
With the spread of the novel coronavirus pneumonia epidemic around the world, the World Health Organization classifies the novel coronavirus pneumonia epidemic as a global pandemic. This epidemic has brought severe challenges to the public health undertakings of all countries. It has also brought about major economic problems and inevitably caused negative effects. However, COVID-19 has objectively improved the infection prevention and control business of the blood irradiation company and can test the company's efficient operation capabilities. In order to cope with the negative impact of the epidemic, blood exposure companies will adopt a variety of methods to promote the rapid normalization of major business areas, maintain and meet the normal needs of customers during the epidemic, and minimize adverse effects.
Innovative research on laser blood irradiation against COVID-19
Many scientists have confirmed the importance of basic research to study the pathogenic mechanism of COVID-19 destroying various organs and systems in the human body, to prove and develop new treatment methods using laser blood irradiation. It is noted that it is necessary to consider and comprehensively evaluate the results of world scientific research on the development of a vaccine for large-scale prevention of coronavirus infection, and the possibility of global scientists to solve this problem.
Under the public background of the COVID-19 crisis, the industry is being affected by COVID-19. It is currently impossible to accurately predict the degree of control of this epidemic in various countries, and it is impossible to predict whether it will function normally for long-term economic activities.
However, historical data shows that the impact of natural disasters on the macro economy is usually short-term, and the economy often shows a V-shaped trend. Affected by the disaster and market sentiment, the economic growth rate usually drops sharply in a short period of time, but as the disaster is gradually controlled, the market sentiment returns to stability, and the temporarily suppressed consumption and investment needs will be released, resulting in Economic rebound. The outbreak of the epidemic will have a significant impact on enterprises and individuals within a certain period of time, especially on small and medium-sized enterprises and low-income families. It is necessary for the government to take targeted financial and monetary measures to help all walks of life together.
Region Overview:
From 2022-2027, North America is estimated to witness robust growth prospects
Company Overview:
Hitaci, Best Theratronics, Gilardon iwere the top 3 players in the Blood Irradiation market in 2022, taking up a market share of 74% together.
Segmentation Overview:
Among different product types, X-ray Blood Irradiation segment is anticipated to contribute the largest market share in 2027.
X-ray Blood Irradiation
X-ray blood irradiation uses X-ray tubes to generate X-rays instead of isotope sources. When the tube is powered on, radiation is generated, and the radiation output can be stopped when the power is turned off, which ensures the controllable environmental radiation hazard from the working principle. X-rays are widely used in the medical field, with mature protection technology and no radioactive waste. Compared with gamma rays, X-rays are safer and more reliable in terms of personnel operation, management and maintenance.
Gamma-ray Blood Irradiation
The principle of gamma-ray radiation to prevent TA-GCHD is to use the radiation generated in the decay of the radioisotope 137Cs to penetrate nucleated cells, directly cause irreversible damage to nuclear DNA and interfere with its normal repair process, causing lymphocytes to lose mitotic activity and stop proliferation.
Application Overview:
By application, the Blood Bank segment occupied the biggest share from 2017 to 2022.
The Blood Irradiation market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Blood Irradiation market covered in Chapter 4:
Gilardoni
CIF medical
Hitaci
JL SHEPHERD & ASSOCIATES
Gamma-Service
Shinva Medical
Rad Source
Best Theratronics
In Chapter 12 and Chapter 14.1, on the basis of types, the Blood Irradiation market from 2018 to 2028 is primarily split into:
X-ray Blood Irradiation
Gamma-ray Blood Irradiation
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Blood Irradiation market from 2018 to 2028 covers:
Blood Bank
Hospital
Research Institutions
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Blood Irradiation market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Blood Irradiation market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Blood Irradiation industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Blood Irradiation industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Blood Irradiation market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Blood Irradiation market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Blood Irradiation market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Blood Irradiation market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
